View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. DPT Laboratories
15 October 2013

DPT Laboratories and Confab Announce Integration

Pharmaceutical contract development and manufacturing organizations (CDMOs) DPT Laboratories and Confab today announced the integration of the organizations under the leadership of Paul Johnson, group president and COO.

Both DPT and Confab are owned by Renaissance Acquisition Holdings, LLC, a portfolio company of RoundTable Healthcare Partners, and represent its CDMO holdings.

The integration includes a re-branding and new logo for Confab, identifying it as a DPT company. A primary focus of the integration is for DPT’s established sales and marketing team to introduce Confab’s specialized expertise in complex solid, semi-solid and liquid dosage forms to new pharmaceutical industry clients, especially in the US market.

The management teams for both companies will remain in place, with Confab development and manufacturing continuing to operate under the direction of president and general manager Nathalie Brisson.

"Confab is one of the most-respected pharmaceutical outsourcing organizations in Canada, with more than 30 years’ experience in manufacturing, packaging and analyzing a wide range of projects for both large and small pharmaceutical companies," said Johnson.

"The integration will provide our sales team with complimentary manufacturing capabilities and a broader range of services to offer to our customers," he added. "At the same time, the increased marketing support will leverage the continued investment Confab has made in infrastructure and capabilities, paying dividends in new client development and increased sales growth."

Confab has 350 employees and a 140,000ft², cGMP-compliant turnkey facility, which is licensed by the Health Canada Therapeutic Products Directorate, as well as the United States Food and Drug Administration.

"DPT’s sales and marketing team has a proven track record for building client relationships and driving growth," said Brisson. "For our team at Confab, this will mean broader recognition of our capabilities and services, access to new markets and increased opportunities for growth."

DPT, the industry leader for semi-solids and liquids, has research and development as well as manufacturing facilities in San Antonio, TX, as well as in Lakewood, NJ, where it is expanding its presence in the sterile and specialty products markets.

Pharmaceutical drug product development can be an expensive and time-consuming process. Many challenges are faced by pharmaceutical development companies including developing a scaleable, marketable formulation,...
With the increased globalisation and complexity of the pharmaceutical supply chain, managing the sourcing of materials has become extremely challenging. Reducing time and costs are...
This paper describes the approach and benefits of using DPT Labs' QbD Scale Up service and follows the third paper in our Thought Leadership Series,...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology